NCT01327612 2021-02-21Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)AmgenPhase 2 Completed12 enrolled 21 charts
NCT00580320 2016-08-18Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue SarcomaVirginia Commonwealth UniversityPhase 1 Completed17 enrolled
NCT00314925 2010-02-25Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine FeaturesNeotropixPhase 1 Unknown60 enrolled